Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune ...

On February 2, 2026, the U.S. Food and Drug Administration’s long-awaited harmonization of the medical device good manufacturing practice ...

Today’s newsletter is about the Chinese government, a biolab, and reckless handling of dangerous pathogens. No, it’s not 2020.

Enterprise AI can’t scale without a semantic core. The future of AI infrastructure will be built on semantics, not syntax.

The Marshall Project found more than 70,000 cases referred to law enforcement over allegations of substance use during ...

WHAT WE’RE ALL READING: Ten days on from the DOJ’s mass dump of Epstein files data, the revelations keep coming. The files thus far have largely exposed a murky world of conspiring elites with ...

Today we're delving into the art of shaken cocktails, using the daiquiri as a prime example to distinguish amateur bartenders from professionals. Joe explains the daiquiri as a perfect example of the ...

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S.

Shanghai-based Harbour BioMed’s acquisition of a stake in US-based Spruce Biosciences is the latest example of China’s novel drug developers progressing from one-time licensing deals into long-lasting ...

Lawmakers want an independent “special master” to oversee the Trump administration’s release of its files on Jeffrey Epstein, potentially helping to ensure all the files will be made public after the ...

The U.S. Justice Department has asked a New York federal judge to deny a request by two lawmakers seeking an appointment ⁠of a special master to monitor the public release of records tied to the late ...